Stocks · Healthcare · Medical - Healthcare Plans
UnitedHealth Group Incorporated UNH
$371.90 +1.83% Close, Oct 2, 2026 · NYSE · Market cap $337.74B
Inexpensive vs sectorLow risk
Next earnings report: Oct 13, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in an uptrend: above its 200-day average for 121 trading days, with the 50-day average above the 200-day.
- Earnings beat analyst estimates in each of the last 4 quarters (average surprise over the last four: +11.5%).
- Diluted EPS over the last four quarters was $15.55, down 32.6% year over year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth30Weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 44%
- EPS growth (TTM, YoY)Bottom 32%
- FCF growth (TTM, YoY)Bottom 36%
- Revenue growth, 3-year CAGRTop 47%
- Revenue growth accelerationBottom 31%
Quality70Positive
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 16%
- Gross marginBottom 16%
- Operating marginTop 35%
- Cash conversion (OCF / net income)Top 34%
- Accruals (lower is better)Bottom 36%
- Net debt / EBITDA (lower is better)Bottom 43%
- Interest coverTop 25%
Value91Exceptional
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 13%
- Free-cash-flow yieldTop 12%
- EBITDA / enterprise valueTop 17%
- Sales / enterprise valueTop 7%
- P/E vs own 5-year history (lower is better)Top 48%
Momentum59Neutral
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 45%
- 6-month returnTop 28%
- 1-year return vs S&P 500Bottom 47%
- Distance from 52-week highTop 31%
- Trend checklist (0–4)Top 39%
Revisions75Positive
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 35%
- Consecutive EPS beatsTop 19%
- Share of analysts rating BuyTop 40%
- Upside to consensus price targetBottom 33%
Stability85Strong
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 2%
- Maximum drawdown, 3 yearsTop 38%
- Beta vs S&P 500 (lower is better)Top 13%
- Net debt / EBITDA (lower is better)Bottom 43%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 9.7% | 6.5% | ↓ |
| EPS growth (YoY) | -44.6% | -32.6% | ↑ |
| Gross margin | 20.8% | 22.5% | ↑ |
| Operating margin | 7.3% | 4.8% | ↓ |
| FCF margin | 6.0% | 5.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 6.5% | 9.7% | ↓ | Bottom 44% |
| EPS growth (TTM, YoY) | -32.6% | -44.6% | ↑ | Bottom 32% |
| Gross margin | 22.5% | 20.8% | ↑ | Bottom 16% |
| Operating margin | 4.8% | 7.3% | ↓ | Top 35% |
| Net margin | 3.1% | 5.0% | ↓ | — |
| Free-cash-flow margin | 5.2% | 6.0% | ↓ | — |
| Return on invested capital | 9.2% | — | Top 16% | |
| Revenue growth, 3-year CAGR | 11.4% | — | Top 47% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.91×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -18.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.74×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 5.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 2.40%
- Net buyback yield (TTM)
- 0.59%
- Shareholder yield
- 2.99%
- Share count change, 1 year
- -0.4%
- Share count change, 3-year CAGR
- -1.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +11.5%
- Average 2-day reaction, last 8
- -6.9%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $473.89
- Target vs current price
- +27.4%
- Analysts with a rating
- 52
- Share rating Buy or Strong Buy
- 83%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 16, 2026 | +29.1% | +1.2% | +3.1% | -3.1% | — |
| Apr 21, 2026 | +11.9% | +7.0% | +9.6% | +20.9% | +30.9% |
| Jan 27, 2026 | +0.5% | -19.6% | -18.8% | -22.1% | +0.5% |
| Oct 28, 2025 | +4.3% | +0.5% | -8.8% | -12.8% | -2.7% |
| Jul 29, 2025 | -8.3% | -7.5% | -14.6% | +8.1% | +29.5% |
| Apr 17, 2025 | -1.2% | -22.4% | -27.5% | -53.1% | -50.1% |
| Jan 16, 2025 | +1.0% | -6.0% | -2.5% | -2.3% | +10.3% |
| Oct 15, 2024 | +2.1% | -8.1% | -5.6% | +3.3% | -14.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 16, 2026 | $6.38 | $4.94 | +29.1% | $112.03B |
| Apr 21, 2026 | $7.23 | $6.46 | +11.9% | $112.03B |
| Jan 27, 2026 | $2.11 | $2.10 | +0.5% | $113.22B |
| Oct 28, 2025 | $2.92 | $2.80 | +4.3% | $113.16B |
| Jul 29, 2025 | $4.08 | $4.45 | -8.3% | $111.62B |
| Apr 17, 2025 | $7.20 | $7.29 | -1.2% | $109.58B |
| Jan 16, 2025 | $6.81 | $6.74 | +1.0% | $100.81B |
| Oct 15, 2024 | $7.15 | $7.00 | +2.1% | $99.18B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 23.9× | 26.4× | 43th | Top 13% |
| P/E (forward) | 18.6× | — | — | — |
| EV / EBITDA | 14.8× | — | — | Top 17% |
| EV / Sales | 0.85× | — | — | Top 7% |
| Free-cash-flow yield | 6.99% | — | — | Top 12% |
| Earnings yield | 4.18% | — | — | Top 13% |
P/E over the past five years
Range 10.9× – 37.0× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +6.8%
- Earnings per share growth (TTM)
- -32.6%
- Change in P/E multiple
- +140.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 121
- 50-day average slope (20 days)
- -4.5%
- 200-day average slope (20 days)
- +1.5%
- Distance from 50-day average
- -5.5%
- Distance from 200-day average
- +4.4%
- RSI (14)
- 40.4
- Relative volume
- 0.64×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 21.2%
- Volatility vs own 5-year history
- 19th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.44
- Correlation with S&P 500
- 0.15
- Current drawdown from 1-year high
- -14.8%
- Maximum drawdown, 3 years
- -62.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 11, 2024 | Aug 1, 2025 | -62.0% | 179 days | Not yet recovered |
| Oct 31, 2022 | Apr 12, 2024 | -20.9% | 363 days | 65 days (Jul 17, 2024) |
| Apr 20, 2022 | Jun 17, 2022 | -17.2% | 41 days | 40 days (Aug 16, 2022) |
| Jan 7, 2021 | Feb 8, 2021 | -11.2% | 21 days | 28 days (Mar 19, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $337.74B
- P/E (TTM)
- 23.9
- EPS, diluted (TTM)
- $15.55
- Revenue (TTM)
- $450.13B
- Dividend yield
- 2.44%
- 52-week range
- $255.97 – $461.62
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $287.60B | $324.16B | $371.62B | $400.28B | $447.57B |
| Gross profit | $69.65B | $79.62B | $90.96B | $89.40B | $82.92B |
| Operating income | $23.97B | $28.43B | $32.36B | $32.29B | $18.96B |
| Net income | $17.29B | $20.12B | $22.38B | $14.40B | $12.06B |
| EPS (diluted) | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $100.82B | $100.81B | $109.58B | $111.62B | $113.16B | $113.22B | $111.72B | $112.03B |
| Net income | $6.05B | $5.54B | $6.29B | $3.41B | $2.35B | $10.0M | $6.28B | $5.48B |
| EPS (diluted) | $6.51 | $5.98 | $6.85 | $3.74 | $2.59 | $0.01 | $6.90 | $6.05 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $22.34B | $26.21B | $29.07B | $24.20B | $19.70B |
| Capital expenditure | -$2.45B | -$2.80B | -$3.39B | -$3.50B | -$3.62B |
| Free cash flow | $19.89B | $23.40B | $25.68B | $20.70B | $16.07B |
| Dividends paid | -$5.28B | -$5.99B | -$6.76B | -$7.53B | -$7.92B |
| Net share buybacks | -$3.65B | -$5.75B | -$6.65B | -$7.15B | -$5.54B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $31.47B
- Total assets
- $309.73B
- Total liabilities
- $205.11B
- Total debt
- $73.33B
- Net debt
- $44.74B
- Shareholders’ equity
- $98.45B
As of Jun 30, 2026 (filed Aug 10, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 14, 2026 | $2.32 | Sep 22, 2026 |
| Jun 15, 2026 | $2.32 | Jun 23, 2026 |
| Mar 9, 2026 | $2.21 | Mar 17, 2026 |
| Dec 8, 2025 | $2.21 | Dec 16, 2025 |
| Sep 15, 2025 | $2.21 | Sep 23, 2025 |
| Jun 16, 2025 | $2.21 | Jun 24, 2025 |
| Mar 10, 2025 | $2.10 | Mar 18, 2025 |
| Dec 9, 2024 | $2.10 | Dec 17, 2024 |
Short interest
- Shares sold short
- 13,216,124
- Days to cover
- 2.47
- Change vs previous report
- -13.6%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- May 31, 2005
- 2-for-1
- Jun 19, 2003
- 2-for-1
- Dec 26, 2000
- 2-for-1
- Mar 11, 1994
- 2-for-1
- Sep 16, 1992
- 2-for-1